Anti‐CD20 mAb maintenance therapy vs observationHealth‐related quality of life · people with chronic lymphocytic leukaemia1 finding from 1 reviewMaintenance therapy for chronic lymphocytic leukaemia 2024 · Cochrane Headline outcomes onlyno estimate extracted1 study · 480 participantsLow